Domingos Janine, Casimiro Anaxore, Portugal-Calisto Daniela, Varandas Luís, Nogueira Fátima, Silva Marcelo Sousa
Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Portugal.
Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Portugal; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Acta Trop. 2018 Sep;185:46-51. doi: 10.1016/j.actatropica.2018.04.020. Epub 2018 Apr 21.
Malaria is a parasitic disease of which Plasmodium falciparum causes the most severe form of the disease. The immune response against Plasmodium spp. is complex and remains unclear. The present report aimed to better understand the humoral immune response in severe malaria and analyse new immunodominant antigen candidates as possible serological marker in severe malaria in children. This study included children aged 0-16 years from Guinea-Bissau with clinical signs of severe malaria. Serological and immunochemical characterisation of different anti-P. falciparum antibodies were made by ELISA and immunoblotting using a crude protein extract of P. falciparum. Sera from 12 children with severe malaria were analysed. Nine samples were positive for total anti-P. falciparum antibodies, seven for IgM and eight for total IgG anti-P. falciparum. There was a predominance of IgG1 response, suggesting a cytophilic action in severe malaria and a major role of IgG1 over other immunoglobulins. The antigenic profile of P. falciparum showed a consistent immunoblotting pattern of approximately 180 kDa, 100 kDa and around 50-40 kDa. The serological reactivity found in protein bands makes them as immunodominant antigens and promising candidates for serological markers in the context of severe malaria.
疟疾是一种寄生虫病,其中恶性疟原虫会引发最严重的疟疾形式。针对疟原虫属的免疫反应复杂且尚不清楚。本报告旨在更好地了解重症疟疾中的体液免疫反应,并分析新的免疫显性抗原候选物,作为儿童重症疟疾可能的血清学标志物。本研究纳入了来自几内亚比绍的0至16岁有重症疟疾临床症状的儿童。通过酶联免疫吸附测定(ELISA)以及使用恶性疟原虫粗蛋白提取物进行免疫印迹,对不同抗恶性疟原虫抗体进行血清学和免疫化学表征。分析了12名重症疟疾患儿的血清。9份样本的抗恶性疟原虫总抗体呈阳性,7份IgM呈阳性,8份抗恶性疟原虫总IgG呈阳性。存在IgG1反应优势,表明在重症疟疾中存在亲细胞作用,且IgG1比其他免疫球蛋白起主要作用。恶性疟原虫的抗原谱显示出一致的免疫印迹模式,约为180 kDa、100 kDa以及50 - 40 kDa左右。在蛋白条带中发现的血清学反应性使其成为免疫显性抗原,并且是重症疟疾背景下血清学标志物的有前景的候选物。